How WHO-GMP Certification Works for Pharmaceutical Exporters

Quick answer: WHO-GMP (World Health Organization Good Manufacturing Practices) certification confirms that a pharmaceutical manufacturing facility meets WHO’s quality and safety standards for producing medicines. It is issued not by the WHO itself, but by the national drug regulatory authority of the manufacturer’s home country — in India, by the State Drug Controller in coordination with CDSCO — after a physical inspection of the facility against WHO Technical Report Series 961, Annex 3. It’s required for import registration and tender participation across most of Africa, the Middle East, South and Southeast Asia, and Latin America, and it certifies the facility, not any single product batch.

If you’ve spent any time sourcing medicines from an overseas manufacturer, you’ve almost certainly run into three letters that show up on every second product catalog: GMP. And right in front of it, more often than not, sits another set of letters — WHO.

WHO-GMP. It sounds like a bureaucratic stamp, the kind of thing you nod at and move past. But if you’re an importer, a distributor, or a procurement officer responsible for getting medicines across a border and onto a pharmacy shelf, this certificate is one of the first things you should actually stop and read carefully. It tells you whether the factory behind the product label is capable of making medicine safely and consistently — and whether your shipment is going to sail through customs or sit in a bonded warehouse while someone asks awkward questions.

This guide walks through what WHO-GMP certification actually is, how a manufacturer earns it, what it does (and doesn’t) guarantee you as a buyer, and how to verify one in under ten minutes instead of taking a supplier’s word for it.

Key Takeaways

• WHO-GMP certification is issued by a national drug regulator, not directly by the WHO, based on WHO’s published GMP guidelines.
• It certifies a specific manufacturing facility and product scope — not a company as a whole, and not automatic market access in your country.
• It’s typically valid for two to three years and requires re-inspection to renew.
• Always verify the certificate number, facility address, and product scope directly with the issuing authority before signing a supply agreement.
• WHO-GMP sits below US FDA GMP and EU-GMP in inspection rigor, but it’s the standard most global pharmaceutical trade actually runs on.

What Does WHO-GMP Actually Mean?

WHO-GMP stands for World Health Organization Good Manufacturing Practices. It’s a set of quality standards published by the WHO that spells out how a pharmaceutical manufacturing facility should be designed, staffed, operated, and documented so that every batch of medicine coming off the line is safe, effective, and exactly what the label says it is.

Here’s the part that trips people up: the WHO doesn’t send its own inspectors to a factory in Hyderabad or Ahmedabad and hand out a certificate with its logo on it. The WHO writes the standard. The certification itself is issued by the national drug regulatory authority of the country where the manufacturer is based — in India, that’s the Central Drugs Standard Control Organisation (CDSCO), working through the respective State Drug Controller. So when you see “WHO-GMP Certified” on an Indian manufacturer’s documents, what you’re really looking at is a Certificate of Pharmaceutical Product (COPP) or a GMP compliance certificate issued by the State FDA, confirming the facility meets WHO’s GMP guidelines — specifically the ones laid out in WHO Technical Report Series 961, Annex 3.

That distinction matters more than it seems. A lot of confusion (and, frankly, a lot of misrepresentation by less scrupulous suppliers) comes from blurring the line between “WHO published these standards” and “WHO personally inspected this factory.” They didn’t. Your national regulator did, using the WHO’s framework.

Why WHO-GMP Exists in the First Place

Before GMP frameworks existed, pharmaceutical manufacturing was a much riskier business than most people realize. Batch-to-batch consistency wasn’t guaranteed, cross-contamination between products wasn’t systematically prevented, and record-keeping was often an afterthought. A handful of serious public health disasters in the mid-20th century — including contaminated and mislabeled drugs that caused real harm — pushed regulators worldwide toward formal manufacturing standards.

The WHO stepped in because a huge share of the world’s population, particularly in low- and middle-income countries, depends on medicines sourced internationally, often without the resources to run their own exhaustive facility inspections. WHO-GMP became the common language: a baseline that importing countries, especially those without a stringent regulatory authority of their own, could rely on when deciding whether a foreign manufacturer’s medicines were safe to bring in.

That’s also why WHO-GMP certification carries real weight in international trade. It’s frequently a prerequisite for:

• Tender participation with government health ministries and NGOs (UNICEF, Global Fund, and similar procurement bodies typically require it)
• Import registration in countries across Africa, Southeast Asia, the Middle East, and Latin America
• Getting listed with WHO’s own Prequalification Programme
• Simply being taken seriously by a distributor doing due diligence before signing a multi-year supply agreement

WHO-GMP vs. Other GMP Certifications: What’s the Actual Difference?

This is where most first-time buyers get genuinely confused, so let’s untangle it properly.

WHO-GMP is the baseline most exporting countries operate under. It’s recognized broadly across Asia, Africa, the Middle East, and Latin America, and it’s the minimum standard for participating in most public tenders in those regions.

US FDA GMP (21 CFR Parts 210 and 211) is enforced by the U.S. Food and Drug Administration and is required for any manufacturer shipping finished pharmaceuticals or APIs into the United States. FDA inspections tend to be more intensive, unannounced, and data-integrity focused than a typical WHO-GMP audit.

EU-GMP is issued by the national regulatory authority of an EU member state (or the UK’s MHRA, which maintains its own equivalent post-Brexit) and is required for exporting into the European Union. EU-GMP inspections are notoriously thorough, especially around data integrity, environmental monitoring, and qualified person (QP) release procedures.

PIC/S GMP isn’t a separate standard so much as a mutual recognition framework — the Pharmaceutical Inspection Co-operation Scheme harmonizes GMP inspection standards across more than 50 participating regulatory authorities, so a facility inspected under PIC/S guidelines is generally trusted across all member countries without needing a fresh inspection each time.

Here’s the practical way to think about the hierarchy: US FDA and EU-GMP sit at the top in terms of scrutiny and global recognition, PIC/S sits close behind because of its cross-border trust mechanism, and WHO-GMP forms the wide base that most of the world’s importing pharmaceutical trade actually runs on. A facility can — and often does — hold WHO-GMP plus one or more of the stricter certifications simultaneously, because each one unlocks a different set of export markets. If you’re buying for a market that mandates FDA or EU-GMP, a WHO-GMP certificate alone won’t clear customs. If you’re buying for most of Africa, the Middle East, or South/Southeast Asia, WHO-GMP is usually exactly what you need, and demanding FDA-level documentation would be overkill.

A Quick Side-by-Side Comparison

If you’re evaluating a supplier for the first time, this table is a useful gut-check: ask which of these your supplier actually holds, for which product lines, and cross-reference that against where you plan to sell.

How a Manufacturer Actually Gets WHO-GMP Certified

Buyers rarely see this part of the process, but understanding it helps you ask sharper questions of your supplier — and spot the difference between a manufacturer that treats compliance as a living system versus one that scrambled to pass a one-time inspection.

1. Building the Quality Management System

Before a facility can even apply, it needs a documented Quality Management System (QMS) covering everything from raw material sourcing to finished product release. This includes Standard Operating Procedures (SOPs) for manufacturing, cleaning, equipment calibration, personnel hygiene, and deviation handling. Regulators aren’t just checking whether the SOPs exist — they’re checking whether staff on the floor actually follow them day to day.

2. Facility and Equipment Design

The plant layout itself has to meet GMP expectations: separate zones to prevent cross-contamination, appropriate air handling systems (HVAC with HEPA filtration in critical areas), validated water systems, and equipment that’s been qualified (Installation Qualification, Operational Qualification, Performance Qualification — commonly shortened to IQ/OQ/PQ) rather than just installed and switched on.

3. Documentation and Batch Records

Every batch produced needs a Batch Manufacturing Record (BMR) and Batch Packaging Record (BPR) that traces the product from raw material to finished pack — who did what, when, using which equipment, with what results at each checkpoint. Inspectors lean heavily on these records during an audit because paperwork gaps are often the first sign of deeper process gaps.

4. Application to the State Drug Controller

The manufacturer applies to their respective State Licensing Authority (in India, this runs through the State FDA in coordination with CDSCO) for WHO-GMP certification, submitting the site master file, product details, and supporting documentation.

5. The Inspection

A team of drug inspectors visits the facility — sometimes announced, sometimes with limited notice — and physically walks the plant. They’ll check manufacturing areas, quality control labs, warehousing, documentation practices, and interview staff. They’re looking for things like: are gowning procedures actually followed, are calibration records current, is there evidence of proper cleaning validation between product changeovers, and do deviation and CAPA (Corrective and Preventive Action) systems show real follow-through rather than boxes ticked for show.

6. Addressing Observations

It’s rare for a facility to pass with zero observations on the first attempt. More commonly, inspectors issue a list of findings, and the manufacturer has a defined window to respond with corrective actions — sometimes with a follow-up inspection to verify the fixes actually stuck.

7. Certificate Issuance

Once the facility satisfies the inspection requirements, the state authority issues the WHO-GMP certificate, typically valid for a defined period (commonly two to three years, depending on the jurisdiction), after which the facility must go through renewal, including a fresh inspection.

How Long the Whole Process Realistically Takes

Suppliers and consultants love to quote optimistic timelines, so here’s a more grounded picture of what each phase tends to look like for a facility building its systems from a reasonable but not fully mature starting point:

Put together, a facility starting from a partially compliant baseline is often looking at somewhere between six months and over a year before it holds a certificate in hand. A facility renewing an already-compliant site moves much faster, sometimes in a matter of weeks, because most of the heavy lifting was already done in prior cycles.

What It Costs a Manufacturer to Get There

This isn’t something buyers usually ask about, but it’s worth understanding, because it explains why some suppliers cut corners and others don’t. Certification itself — the government application and inspection fees — is a relatively small line item. The real cost sits in getting the facility ready: HVAC and cleanroom upgrades, water purification systems, calibrated equipment, laboratory instrumentation, staff training, and the ongoing cost of maintaining a documentation and quality team year-round. For a mid-sized facility, total investment to reach and sustain WHO-GMP compliance can run into the tens of lakhs of rupees annually once you factor in equipment maintenance, requalification, and personnel. Manufacturers who’ve made that investment properly tend to be the ones with fewer surprises down the line — which is really the whole point of checking for the certificate in the first place.

What WHO-GMP Certification Actually Guarantees You

It’s worth being precise here, because overselling what a certificate covers is one of the more common ways buyers end up disappointed.

It does guarantee, reasonably reliably:

• The facility has a functioning quality management system and documented procedures
• Manufacturing areas meet baseline cleanliness, environmental control, and contamination-prevention standards
• Batch records exist and are traceable
• Staff have documented training relevant to their roles
• The facility passed a government inspection against WHO’s published GMP framework within the certificate’s validity period

It does not automatically guarantee:

• That every single batch you receive will be defect-free (GMP reduces risk substantially, it doesn’t eliminate it)
• That the specific product you’re buying has been through additional country-specific registration in your target market (WHO-GMP and product marketing authorization are two separate things)
• That the facility maintains the same standard between inspections without ongoing internal discipline (this is why repeat audits and buyer-side quality agreements matter)
• Anything about pricing, lead times, or commercial reliability — that’s a separate conversation entirely

How to Verify a Supplier’s WHO-GMP Certificate (Don’t Skip This Step)

A depressing number of import disputes trace back to a buyer who took a PDF certificate at face value without checking it against the source. Verification takes a few minutes and can save you months of cleanup later.

Check the issuing authority. The certificate should clearly state which State Drug Controller or CDSCO office issued it, along with a certificate number and issue/expiry date. If any of that is missing or vague, treat it as a red flag.

Match the facility address exactly. Certificates are issued to a specific manufacturing site, not to a company as a whole. A supplier might genuinely hold WHO-GMP certification for one plant while quietly sourcing product from a different, uncertified facility. Always confirm the address on the certificate matches where your product is actually being made.

Confirm the product scope. GMP certificates often specify the dosage forms or therapeutic categories covered (tablets, injectables, ophthalmics, and so on). A facility certified for oral solid dosage forms isn’t automatically certified for sterile injectables — those require separate, and generally stricter, qualification.

Check the validity window. An expired certificate is functionally no certificate at all, regardless of how recently it lapsed.

Cross-verify independently. Reach out to the relevant State FDA or CDSCO directly, or ask your supplier for the certificate reference so you can request confirmation through official channels. Reputable manufacturers won’t hesitate to help you verify — it’s the ones who get evasive about it that deserve more scrutiny, not less.

Ask for the site master file summary. This isn’t standard for every deal, but for larger contracts, requesting a summary of the site master file gives you a much deeper view of the facility’s actual manufacturing scope, equipment list, and quality systems than the certificate alone.

Red Flags That Suggest a Certificate May Not Hold Up

A few patterns show up often enough in disputed import cases that they’re worth naming plainly.

The certificate is a low-resolution scan with no verifiable certificate number. Legitimate certificates include a reference number you can independently check with the issuing authority. If a supplier sends a screenshot with no traceable ID, that’s not proof — it’s a picture.

The manufacturing address on the certificate doesn’t match the factory the supplier describes or shows in photos and videos. This is one of the more common ways buyers get misled — a company holds a certificate for one registered site while actually producing (or subcontracting production) elsewhere.

The supplier is reluctant to let you contact the issuing authority directly. Genuine manufacturers rarely push back on this. Hesitation, deflection, or offering to “handle the verification for you” is worth treating as a signal to slow down.

The certificate’s product scope is vague or unusually broad. Real certificates typically specify dosage forms and categories. A certificate that seems to cover everything from tablets to injectables to ophthalmic solutions under one blanket approval deserves a closer look — sterile and non-sterile manufacturing usually sit under very different qualification requirements.

Pricing that seems disconnected from the compliance investment described above. This isn’t proof of anything on its own, but if a quote is dramatically below what comparable WHO-GMP certified suppliers are charging, it’s worth asking directly how they’re managing costs while maintaining the compliance overhead certification requires.

None of these, on their own, mean a supplier is acting in bad faith — sometimes it’s simply disorganization rather than deception. But each one is a reasonable prompt to ask more questions before a purchase order goes out.

A Realistic Example of How This Plays Out

Picture a mid-sized distributor in East Africa sourcing a generic antibiotic for the first time from an Indian manufacturer they found through a trade directory. The manufacturer’s website prominently displays a “WHO-GMP Certified” badge, and the initial quote looks competitive.

Before placing the order, the distributor’s compliance officer requests the actual certificate rather than relying on the website badge. The certificate lists a manufacturing address in Gujarat, valid for oral solid dosage forms, issued eighteen months earlier with two years remaining before renewal. The officer cross-checks the certificate number with the relevant State FDA office, which confirms the certificate is genuine, active, and tied to that exact facility.

The distributor also requests a product-specific Certificate of Pharmaceutical Product, since their own country’s import regulations require it separately from the facility’s GMP status. The manufacturer provides it within a few days, along with recent batch analysis certificates for the specific product being ordered.

Contrast that with a second scenario: a different supplier offers a similar product at a notably lower price, but when asked for the certificate, sends only a company brochure referencing “international quality standards” without a specific certificate number or issuing authority. Follow-up questions go unanswered for over a week.

The difference between these two scenarios isn’t dramatic or cinematic — it’s just a few extra emails and a phone call. But it’s exactly the kind of due diligence that separates a smooth, repeatable import relationship from one that ends in a customs hold, a rejected batch, or worse.

Why This Matters More for Exporters Than the Certificate Alone Suggests

For a manufacturer, WHO-GMP certification isn’t a one-time hurdle to clear and forget — it’s closer to a maintenance commitment. Regulatory authorities conduct periodic re-inspections, and any significant change to the facility (new equipment, new product lines, structural modifications) can trigger a fresh review. Exporters who treat it as a living discipline rather than paperwork tend to be the ones who survive audits from buyers, tenders, and international bodies without scrambling.

From the buyer’s side, this is precisely why the certificate is worth caring about beyond ticking a compliance box. A manufacturer that’s kept its WHO-GMP status current across multiple renewal cycles, without lapses or corrective-action drama, is telling you something real about how seriously they take consistency — which, in pharmaceuticals, is the entire game. A batch that works perfectly this month and inconsistently next month isn’t a minor inconvenience; it’s a patient safety issue with your name attached to the import paperwork.

Common Mistakes Buyers Make Around WHO-GMP

Assuming WHO-GMP is interchangeable with your destination country’s registration requirements. Certification and product registration are related but distinct processes. Your target country may still require the specific product (not just the facility) to go through its own dossier submission and approval before you can legally import it.

Not checking certificate scope against the actual product ordered. As mentioned above, a broad “WHO-GMP Certified Manufacturer” claim on a company website doesn’t tell you which specific product lines or dosage forms the certificate actually covers.

Relying entirely on a certificate without a quality agreement. A signed quality agreement — outlining specifications, testing protocols, change notification obligations, and recall procedures — gives you contractual recourse that a certificate alone doesn’t.

Skipping a facility audit for large or recurring contracts. For high-volume or long-term supply relationships, an independent third-party audit or a buyer-side visit remains the gold standard, regardless of how solid the certificate looks on paper.

Confusing WHO-GMP with WHO Prequalification. These are two different things. WHO-GMP is a national certification aligned to WHO’s guidelines. WHO Prequalification is a separate, far more rigorous WHO-run programme that evaluates specific products (often for HIV, TB, malaria, reproductive health, and vaccines) for procurement by UN agencies and major donors. A manufacturer can be WHO-GMP certified without any of its products being WHO-prequalified, and vice versa in principle, though in practice prequalification typically requires GMP compliance as a precondition.

A Practical Checklist Before You Sign a Supply Agreement

Before finalizing a deal with a WHO-GMP certified manufacturer, it’s worth running through a short list:

• Confirm the certificate is current and matches the exact manufacturing site
• Confirm the certificate scope covers the specific dosage form and product category you’re ordering
• Request the Certificate of Pharmaceutical Product (COPP) if you need it for your own country’s import registration
• Ask whether the facility holds any additional certifications (FDA, EU-GMP, PIC/S) relevant to markets you may expand into later
• Request recent inspection history, if the supplier is willing to share it, or at least confirm there have been no major unresolved regulatory actions
• Put a written quality agreement in place covering specifications, testing, batch documentation, and recall protocols
• Where volumes justify it, plan an independent audit before your first large purchase order

Quick-Reference Glossary

These are the terms that show up constantly around WHO-GMP, defined in plain language so you can skim this instead of digging through a regulatory PDF.

WHO-GMP: A set of manufacturing quality standards published by the World Health Organization, adopted by national regulators to certify pharmaceutical facilities.

CDSCO: The Central Drugs Standard Control Organisation, India’s national drug regulatory body, which coordinates GMP certification with individual State Drug Controllers.

COPP (Certificate of Pharmaceutical Product): A document, based on the WHO certification scheme, that confirms a specific product is manufactured in a GMP-compliant facility and is approved for sale in the country of origin — often required for import registration abroad.

Site Master File: A document describing a manufacturing facility’s activities, layout, equipment, and quality systems, used by regulators and buyers to assess a plant’s actual capabilities.

IQ/OQ/PQ (Installation, Operational, Performance Qualification): The three-stage process of proving equipment is installed correctly, operates as intended, and performs consistently under real production conditions.

CAPA (Corrective and Preventive Action): The documented process a manufacturer uses to fix a quality problem and prevent it from happening again — a core part of any functioning quality management system.

Batch Manufacturing Record (BMR): A detailed, batch-specific document tracing every step of production, used to verify that a specific batch was made according to approved procedures.

PIC/S (Pharmaceutical Inspection Co-operation Scheme): A mutual recognition framework allowing GMP inspections conducted by one member regulatory authority to be trusted by others in the scheme, reducing duplicate inspections.

What an Inspection Day Actually Looks Like

On paper, a WHO-GMP inspection is a checklist exercise. In practice, it’s a full day (sometimes two or three) of drug inspectors walking the floor with the plant’s quality head, cross-referencing what they see against what’s written down.

It typically starts with an opening meeting, where inspectors outline the scope of the visit. From there, they move through the facility in roughly the order a product would travel — raw material receiving and quarantine, weighing and dispensing, manufacturing and processing areas, packaging lines, finished goods warehousing — pausing to ask staff to explain what they’re doing and why, rather than relying only on management’s account.

Quality control labs get particular attention: inspectors will often ask to see raw analytical data, not just summary reports, because discrepancies between the two are one of the most common sources of serious observations. Calibration logs, cleaning validation records, and environmental monitoring data for critical areas all get pulled and cross-checked.

By the end of the visit, inspectors hold a closing meeting to walk through their observations, categorized loosely by severity, before the facility receives anything in writing. Manufacturers who’ve built genuine quality discipline into daily operations tend to find this stage far less stressful than those trying to reconstruct a paper trail after the fact — which, again, is a useful thing to keep in mind as a buyer sizing up a potential supplier’s culture, not just its certificate.

Related Reading for Buyers Doing Deeper Due Diligence

If you’re building out a sourcing checklist beyond WHO-GMP alone, it’s worth also getting familiar with how the stricter regulatory frameworks work, since your target export market ultimately decides which certification actually matters for your shipment:

• US FDA requirements for importing generic medicines into the United States
• MHRA import rules for medicines entering the UK
• TGA regulations for importing pharmaceuticals into Australia
• How to read and verify a Certificate of Pharmaceutical Product before signing a contract
• What buyers should look for in a pharmaceutical exporter’s site master file

Each of these frameworks answers a slightly different question, but the underlying instinct is the same one this guide has been building toward: don’t take a badge on a website at face value — trace it back to the authority that issued it, confirm what it actually covers, and build your contract around that reality rather than around a marketing claim.

Frequently Asked Questions

Is WHO-GMP certification mandatory for exporting pharmaceuticals from India? It isn’t mandatory for every export destination, but a large share of importing countries — particularly across Africa, Asia, and Latin America — require it for import registration and tender participation, which makes it effectively essential for any manufacturer serious about international trade.

How long does WHO-GMP certification take to obtain? Timelines vary by state and facility readiness, but manufacturers typically need several months to prepare documentation and systems before applying, plus additional time for the inspection and any corrective action cycles. A facility building its quality systems from scratch should expect this to take considerably longer than one simply renewing an existing certificate.

How often does WHO-GMP certification need to be renewed? Validity periods vary by issuing state authority in India, but certificates are commonly valid for two to three years before requiring renewal through a fresh inspection.

Does WHO-GMP certification mean the product is approved for sale in my country? No. It certifies the manufacturing facility, not automatic market access. You’ll typically still need to complete your own country’s product registration or import licensing process separately.

What’s the difference between a WHO-GMP certificate and a Certificate of Pharmaceutical Product (COPP)? The GMP certificate confirms the facility meets manufacturing standards. The COPP is a broader document, often required for import registration, that references the product’s marketing status, formulation, and the manufacturing site’s GMP compliance together.

Can a manufacturer lose its WHO-GMP certification? Yes. If a re-inspection identifies serious non-compliance, or if the facility fails to address corrective actions, the issuing authority can suspend or revoke the certificate.

Is WHO-GMP the same as ISO 9001 certification? No, and this is a common point of confusion. ISO 9001 is a general quality management standard applicable across industries, while WHO-GMP is specific to pharmaceutical manufacturing and addresses concerns unique to drug production, such as cross-contamination control, sterility, and batch traceability. Many manufacturers hold both, but one doesn’t substitute for the other.

Do API (Active Pharmaceutical Ingredient) manufacturers need separate WHO-GMP certification from finished dosage manufacturers? Generally, yes. API manufacturing facilities and finished dosage formulation facilities are typically inspected and certified separately, even when they belong to the same parent company, because the manufacturing processes, equipment, and risk profiles differ significantly between the two.

How do I request a copy of a manufacturer’s WHO-GMP certificate? Simply ask. Legitimate manufacturers include this as standard pre-contract documentation and typically provide it alongside other compliance paperwork, such as the site master file summary, product dossiers, and stability data, without requiring extensive back-and-forth.

What happens if a shipment arrives without proper WHO-GMP backing at customs? Depending on the destination country’s regulations, this can range from delayed clearance while documentation is sorted out, to outright rejection and return of the shipment, to seizure in more serious cases. This is precisely why verifying certification before shipment, rather than after, is worth the extra day or two it takes.

Is WHO-GMP certification the same across every Indian state? The underlying WHO framework is consistent, but certification is administered by individual State Drug Controllers in coordination with CDSCO, which means the specific inspection scheduling, documentation formats, and turnaround times can vary somewhat from state to state.

The Bottom Line

WHO-GMP certification isn’t just a badge on a supplier’s website — it’s a signal, backed by an actual government inspection, that a facility has the systems in place to make medicine consistently and safely. For buyers, it’s a genuinely useful screening tool, but it works best as a starting point for due diligence rather than the finish line. Check the certificate against the actual facility and product, ask the questions suppliers sometimes hope you won’t, and pair it with a solid quality agreement before you commit to a long-term relationship.

The manufacturers worth building a partnership with are usually the ones who make this easy — the ones who hand over documentation without hesitation, welcome an audit, and treat WHO-GMP as a floor they’ve already built well above, not a ceiling they scraped past once and never revisited.